{
    "Trade/Device Name(s)": [
        "VITEK 2 Gram Negative Piperacillin/Tazobactam",
        "VITEK 2 AST-GN Piperacillin/Tazobactam"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K080107",
    "Predicate Device Reference 510(k) Number(s)": [
        "K072038"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "February 28, 2008",
    "Summary Letter Received Date": "January 15, 2008",
    "Submission Date": "January 11, 2008",
    "Regulation Number(s)": [
        "21CFR866.1645"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test System - Short Incubation"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Piperacillin/Tazobactam"
    ],
    "Specimen Type(s)": [
        "Isolated colonies",
        "Aerobic gram-negative bacilli"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK 2",
        "VITEK 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Antimicrobial susceptibility testing",
        "Minimum inhibitory concentration (MIC) microdilution methodology"
    ],
    "Methodologies": [
        "Automated and manual filling/sealing",
        "Incubation cycle with growth monitoring",
        "MIC determination"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Automated system"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 Gram Negative Piperacillin/Tazobactam antimicrobial susceptibility testing assay using automated MIC determination",
    "Indications for Use Summary": "Intended for antimicrobial susceptibility testing of gram-negative organisms using VITEK 2 and VITEK 2 Compact Systems to determine in vitro susceptibility to Piperacillin/Tazobactam.",
    "fda_folder": "Microbiology"
}